Search Results 1281-1290 of 13319 for monoclonal antibody
... monoclonal antibody (mAb) within 4 weeks prior to first dose 3. Received live vaccines within 28 days prior to first administration of the study drug or ...
History of severe allergic or anaphylactic reactions to human, humanized or murine monoclonal antibodies. ... Positive hepatitis BsAg or hepatitis C antibody ...
... antibody detectable targets on cancer cells (cancer vaccines or antibody ... Monoclonal Antibodies To Treat Hospitalized Patients With COVID-19 Rochester, MN.
History of ≥ Grade 3 allergic reactions to monoclonal antibody therapy as well as known or suspected allergy or intolerance to any agent given in the course of ...
The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...
... monoclonal antibody-containing therapy. Note: Relapsed disease is defined as disease that has recurred ≥6 months after completion of therapy. Refractory ...
Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue. These ...
Pertuzumab, an anti-HER2 humanized monoclonal antibody ... In this respect, anti-ErbB2 monoclonal antibody 4D5 specifically inhibits the growth of tumor cells ...
Participation eligibility · Targeted therapeutics other than monoclonal antibodies (e.g., kinases inhibitors) ≤ 2 weeks prior to registration. · Monoclonal ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.